Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Obstructive sleep apnea (FDA approved June 2024 first drug for this indication)
Since exenatide is the only available GLP-1 receptor agonist covered by insurance in Turkey, a drug desensitization protocol, the only therapeutic method in hypersensitivity reactions used in case of absence of an alternative drug, was considered
PMID: 46 WannerCInzucchiSELachinJMFitchettDvon EynattenMMattheusMet al
Provide us your contact information and we will get back to you as soon as possible.
US$ 24.88
US$ 27.83
US$ 23.54
US$ 24.79
US$ 21.39
US$ 29.12
US$ 27.55
US$ 27.41
